Is the weight loss injection available on the NHS — and what are your options?

The decision in front of you: NHS, private, or neither yet

This is a question our prescribers hear most weeks, not because people are trying to skip a queue, but because the information online is genuinely confusing. The short answer is that the NHS does fund weight loss injections, but the criteria are deliberately narrow at this stage, and being clinically overweight or obese is not, on its own, enough to qualify.

NICE recommended tirzepatide in December 2024 (NICE technology appraisal TA1026) and semaglutide in March 2023 (TA875), but NHS England is phasing implementation to manage demand. The practical result is that most adults with obesity will not meet the current NHS threshold for some time. That leaves a real decision: wait and hope criteria expand to include you, pursue a referral if you do qualify, or explore a clinically supervised private route now.

Understanding exactly where the thresholds sit helps. Our guide on weight loss injections on the NHS goes deeper on how the phased rollout works in practice.

Where the NHS criteria stand right now

NHS England's phased rollout for tirzepatide started in June 2025. The first group to become eligible was adults with a BMI of 40 or above who have four or more qualifying conditions from a specific list: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, and type 2 diabetes. From June 2026, the second cohort opened up, adults with a BMI of 35 to 39.9 who also have four or more of those same conditions. A further expansion to BMI 40-plus with three conditions is expected around March 2027.

For some ethnic backgrounds (including South Asian, Chinese, Middle Eastern, Black African, and African-Caribbean) BMI thresholds are reduced by 2.5 kg/m² throughout. Even then, meeting the numbers does not guarantee a place. GP practices can prescribe under the new 2026/27 contract, but participation is optional; some practices have opted in, others have not. Every NHS patient must also take part in wraparound dietary and activity support as a condition of treatment.

Wegovy follows a separate route, available through specialist weight management services under TA875, with its own waiting lists. NHS England's guidance on weight management injections sets out the full picture for both medicines.

When will weight loss injections be more widely available on the NHS?

The phased schedule gives a rough timeline. Lower BMI thresholds and fewer required comorbidities are planned at each stage, meaning more people will qualify progressively through 2027 and beyond. Scotland, Wales, and Northern Ireland operate different frameworks, so eligibility criteria and timelines differ depending on where you live, and if you are currently weighing up whether weight loss injections are available on the NHS for your situation, the devolved picture adds another layer worth understanding before you decide.

The honest caveat is that each expansion depends on health system capacity, budget, and supply. Dates in the rollout plan are approximate. If the current NHS threshold doesn't include you yet, and you are wondering how much a private prescription costs in the meantime, our guide to weight loss injection costs in the UK explains what a legitimate private price covers.

For people who do want to explore what private clinical assessment involves, our page on how to get the weight loss injection walks through the process step by step.

The private route: what it requires and what to check

A regulated private pharmacy can prescribe Mounjaro or Wegovy to adults who meet the licensed criteria, a BMI of 30 or above, or 27 or above with at least one weight-related condition such as hypertension, high cholesterol, type 2 diabetes, or obstructive sleep apnoea. Critically, this requires a genuine clinical assessment: a prescriber reviews your health history, current medicines, and weight before any prescription is issued. That assessment happens at no cost with nume, and is carried out by a GPhC-registered Independent Prescriber, not an automated system.

Before using any online pharmacy, check it appears on the GPhC register. Our GPhC premises registration number is 9012878, verifiable at the GPhC pharmacy register. The MHRA has warned repeatedly about counterfeit weight loss pens sold without clinical oversight, fake pens have contained insulin and caused serious harm. A pharmacy that supplies these medicines without a clinical assessment is not operating legally. The safety profile and what to expect from treatment are covered on our guide to injection safety.

If you'd like to understand the full range of licensed options before deciding anything, our overview of weight loss injections covers both medicines side by side. When you're ready to take the next step, you can check your eligibility with a free consultation, there's no obligation, and a prescriber reviews every submission the same day.